Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
5.61%
↑ 148% above average
Average (22q)
-11.69%
Historical baseline
Range
High:15.11%
Low:-86.99%
Volatility
-873.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 5.61% |
| Q2 2025 | 15.11% |
| Q1 2025 | -13.18% |
| Q4 2024 | -86.99% |
| Q3 2024 | 1.91% |
| Q2 2024 | -6.75% |
| Q1 2024 | 1.75% |
| Q4 2023 | 0.02% |
| Q3 2023 | -21.23% |
| Q2 2023 | -17.45% |
| Q1 2023 | -13.63% |
| Q4 2022 | 4.89% |
| Q3 2022 | 7.80% |
| Q2 2022 | -17.12% |
| Q1 2022 | 13.79% |
| Q4 2021 | -36.91% |
| Q3 2021 | -9.28% |
| Q2 2021 | -41.29% |
| Q1 2021 | -19.22% |
| Q4 2020 | -7.93% |
| Q3 2020 | -26.03% |
| Q2 2020 | -2.82% |
| Q1 2020 | 0.00% |